These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 34509033)

  • 1. Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy-expert opinion.
    Steinhoff BJ; Rosenfeld WE; Serratosa JM; Brandt C; Klein P; Toledo M; Krauss GL
    Epilepsy Behav; 2021 Oct; 123():108270. PubMed ID: 34509033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cenobamate add-on therapy for drug-resistant focal epilepsy.
    Brigo F; Lattanzi S
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014941. PubMed ID: 39087564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper.
    Villani F; Cianci V; Di Bonaventura C; Di Gennaro G; Galimberti CA; Guerrini R; La Neve A; Mecarelli O; Pietrafusa N; Specchio N; Vigevano F; Perucca E
    Expert Rev Neurother; 2022; 22(11-12):935-940. PubMed ID: 36662573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A VAMS-based LC-MS/MS method for precise cenobamate quantification in epilepsy (patients).
    Pigliasco F; Cafaro A; Barco S; Biondi M; Stella M; Mattioli F; Riva A; de Grazia U; Molteni L; Micalizzi E; Villani F; Striano P; Bandettini R; Cangemi G
    Epilepsia Open; 2024 Dec; 9(6):2144-2153. PubMed ID: 39297399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cenobamate, a New Promising Antiseizure Medication: Experimental and Clinical Aspects.
    Błaszczyk B; Czuczwar SJ; Miziak B
    Int J Mol Sci; 2024 Dec; 25(23):. PubMed ID: 39684724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory interventions for focal epilepsy.
    Panebianco M; Walker L; Marson AG
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD009945. PubMed ID: 37842826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of add-on Cenobamate treatment in refractory epilepsy due to Rasmussen's encephalitis.
    Schulze-Bonhage A; Steinhoff B; Garcés M; Hirsch M; Villanueva V
    Epilepsia Open; 2024 Dec; 9(6):2537-2545. PubMed ID: 39388362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S; Ben-Menachem E; Sperling MR; Rosenfeld W; Fountain NB; Benbadis S; Hebert D; Isojärvi J; Doty P
    CNS Drugs; 2010 Dec; 24(12):1041-54. PubMed ID: 21090838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perampanel add-on for drug-resistant focal epilepsy.
    Bresnahan R; Hill RA; Wang J
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010961. PubMed ID: 37059702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Pharmacologic Treatments of Drug-Resistant Epilepsy: Breakthrough in Sight.
    Klein P; Friedman D; Kwan P
    CNS Drugs; 2024 Dec; 38(12):949-960. PubMed ID: 39433725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
    CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands.
    Li N; Majoie M; Evers S; Rijkers K; Gubler F; Rouhl R; Lazeron R; Klarenbeek P; Laskier-Owens V; Hiligsmann M
    J Med Econ; 2024 Dec; ():1-15. PubMed ID: 39686574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches.
    Auvin S; Arzimanoglou A; Falip M; Striano P; Cross JH
    Epilepsia Open; 2024 Dec; ():. PubMed ID: 39700524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian Target of Rapamycin Inhibitor Levels Decrease Under Cenobamate Treatment.
    Becker LL; Agricola K; Ritter DM; Krueger DA; Franz DN
    Pediatr Neurol; 2024 Dec; 161():73-75. PubMed ID: 39305575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures.
    Carreño M; Gil-Nagel A; Serratosa JM; Toledo M; Rodriguez-Uranga JJ; Villanueva V
    Epilepsia Open; 2024 Jun; 9(3):1051-1058. PubMed ID: 38573131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
    Shih JJ; Whitlock JB; Chimato N; Vargas E; Karceski SC; Frank RD
    Epilepsy Behav; 2017 Apr; 69():186-222. PubMed ID: 28237319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of One-Year Anti-seizure Treatment with Add-On Cenobamate on Bone Density and Bone Turnover in Adults with Drug-Resistant Focal Epilepsy: An Observational Study.
    Novitskaya Y; Schulze-Bonhage A; Schütz E; Hirsch M
    CNS Drugs; 2024 Dec; ():. PubMed ID: 39638959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate Treatment of Seizure Clusters: A Conceptual Roadmap to Expedited Seizure Management.
    Wheless JW; Becker DA; Benbadis SR; Puri V; Datta P; Clarke D; Panjeti-Moore D; Carrazana E; Rabinowicz AL
    Neuropsychiatr Dis Treat; 2024; 20():2255-2265. PubMed ID: 39600969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.